SERPINE1 and Hepatic fibrosis: Our data showed that fiber hyperplasia in mice with CCl4-induced liver fibrosis was decreased by treatment with loureirin B, resulting in less hydroxyproline accumulation compared to those not treated with loureirin B. This demonstrated that loureirin B was effective at treating liver fibrosis, presumably through inhibiting PAI-1 activity.